肝细胞癌放射性栓塞后肿瘤控制概率与外照射放疗相似,可用体外放射敏感性预测
该前瞻性研究纳入22例患者的34个肝细胞癌肿瘤,评估基于90Y-TOF-PET的肿瘤等效均匀剂量(EUD)与双分子示踪剂PET/CT代谢反应的相关性,发现吸收剂量与反应高度相关(R=0.72,P<0.001),40 Gy阈值下两组代谢反应差异显著,TCP曲线与外照射放疗相似,EUD 100 Gy可控制肿瘤。
要点
- 吸收剂量与代谢反应高度相关(R=0.72,P<0.001)。
- 40 Gy阈值下两组代谢反应差异显著(中位反应35% vs 100%,P<0.001)。
- EUD 100 Gy可控制肝细胞癌,三种设备均需此EUD。
核心结论
- 基于EUD的90Y TOF-PET/CT可预测肝细胞癌放射性栓塞后的代谢反应,并提供与外照射放疗相似的TCP曲线。
- 体内与体外肝细胞癌放射敏感性相似。
- 两种TCP均显示三种设备(树脂微球、玻璃微球、外照射放疗)需EUD 100 Gy才能控制肝细胞癌。
研究设计与样本
- 前瞻性评估22例患者的34个肝细胞癌肿瘤。
- 代谢反应通过基线至随访的总病变代谢变化(ΔTLM)表征,并计算肿瘤控制概率(TCP)作为肿瘤EUD的函数。
主要发现
- 吸收剂量反应相关性高度显著(R=0.72,P<0.001)。
- 吸收剂量阈值40 Gy时,两组代谢反应差异显著(中位反应35% vs 100%,P<0.001)。
- 放射性栓塞后TCP作为EUD的函数与外照射放疗观察到的非常相似,EUD 51 Gy和100 Gy时TCP值分别为0.5和0.95。
- 假设肿瘤间放射敏感性围绕肝细胞癌细胞体外值变化30%,泊松模型完美预测TCP。
- 达到100 Gy-EUD的观察吸收剂量范围为190至1800 Gy。
关键数值与推荐
- 吸收剂量阈值40 Gy时两组中位代谢反应分别为35%和100%(P<0.001)。
- EUD 51 Gy时TCP为0.5,EUD 100 Gy时TCP为0.95。
- 三种设备(树脂微球、玻璃微球、外照射放疗)均需EUD 100 Gy控制肝细胞癌。
- 达到100 Gy-EUD的观察吸收剂量范围为190至1800 Gy。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tumor equivalent uniform dose (EUD) is proposed as a predictor of patient outcome after liver radioembolization (RE) of hepatocellular carcinoma (HCC) and can be evaluated with 90Y-TOF-PET. The aim is to evaluate the correlation between PET-based tumors EUD and the clinical response evaluated with dual molecular tracer (11C-acetate and 18F-FDG) PET/CT post-RE. METHODS: 34 HCC tumors in 22 patients were prospectively evaluated. The metabolic response was characterized by the total lesion metabolism variation (ΔTLM) between baseline and follow-up. This response allowed to compute a tumor control probability (TCP) as a function of the tumor EUD. RESULTS: The absorbed dose response correlation was highly significant (R = 0.72, P < 0.001). With an absorbed dose threshold of 40 Gy, the metabolic response was strongly different in both groups (median response 35% versus 100%, P < 0.001). Post-RE TCP as a function of the EUD was very similar to that observed in external beam radiation therapy (EBRT), with TCP values equal to 0.5 and 0.95 for a EUD of 51 Gy and 100 Gy, respectively. The TCP was perfectly predicted by the Poisson model assuming an inter tumor radiosensitivity variation of 30% around the HCC cell in vitro value. CONCLUSIONS: EUD-based 90Y TOF-PET/CT predicts the metabolic response post-RE in HCC assessed using dual molecular PET tracers and provides a similar TCP curve to that observed in EBRT. In vivo and in vitro HCC radiosensitivities are similar. Both TCPs show that a EUD of 100 Gy is needed to control HCC for the three devices (resin spheres, glass spheres, EBRT). Observed absorbed doses achieving this 100 Gy-EUD ranged from 190 to 1800 Gy!
引用
- d'Abadie P, Walrand S, Hesse M, et al. TCP post-radioembolization and TCP post-EBRT in HCC are similar and can be predicted using the in vitro radiosensitivity. EJNMMI Res. 2022. PMID: 35802307. doi:10.1186/s13550-022-00911-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。